
Orchestra BioMed Holdings, Inc.
NASDAQ:OBIO
Overview | Financials
Company Name | Orchestra BioMed Holdings, Inc. |
Symbol | OBIO |
Currency | USD |
Price | 2.87 |
Market Cap | 109,956,875 |
Dividend Yield | 0% |
52-week-range | 2.37 - 8.87 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. David P. Hochman |
Website | https://orchestrabiomed.com |
An error occurred while fetching data.
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD